At 7.1% CAGR, Asia Pacific Colostrum Market is Projected to be Worth US$ 765.25 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Asia Pacific colostrum market was valued at US$ 441.75 million in 2023 and is expected to reach US$ 765.25 million by 2031, registering a CAGR of 7.1% from 2023 to 2031. Rising demand for colostrum-based cosmetics and personal care products and technological advancements in colostrum processing are among the critical factors attributed to drive the Asia Pacific colostrum market growth.

Colostrum is utilized as a major ingredient in some high-quality cosmeceutical products that helps protect against external factors. Growth factors present in colostrum help in the cell’s growth and regeneration. Additionally, colostrum reduces skin irritation and aids in the healing of skin defects. It enhances skin hydration and has strong antimicrobial properties. Colostrum-based cosmetics brighten facial skin, slow the aging process, and contribute to better elasticity and resistance of the skin. For instance, Viveza Holding's brand MCE Pharma offers a complete range of premium cosmetics that are preferred by the higher class, along with similar kinds of products in an economic range. Similarly, SwissBioColostrum AG – Switzerland based personal care manufacturers offers colostrum-based body lotion. With the rising popularity and demand, advanced skincare products infused with colostrum are being introduced by manufacturers who are constantly improving their compositions. For example, in July 2023, a Royal Family Farms – Pacific Northwest dairy farm known for its national award-winning sustainability efforts, especially with vermiculture, launched a skincare line called “Nurst,” which is made from excess colostrum from dairy cows. Increasing product launches and the growing cosmetic industry across the globe are expected to drive the demand for colostrum-based cosmetics. Thus, the rising demand for colostrum-based cosmetics and personal care products is expected to create a new trend in the colostrum market over the forecast period.

On the contrary, the increasing veganism trend worldwide hampers the growth of Asia Pacific colostrum market.

Based on form, the Asia Pacific colostrum market is bifurcated into dry and liquid. The dry segment held 89.7% market share in 2023, amassing US$ 396.10 million. It is projected to garner US$ 688.55 million by 2031 to register 7.2% CAGR during 2023–2031.

In terms of category, the Asia Pacific colostrum market is bifurcated into conventional and organic. The conventional segment held 81.8% share of Asia Pacific colostrum market in 2023, amassing US$ 361.22 million. It is anticipated to garner US$ 621.21 million by 2031 to expand at 7.0% CAGR during 2023–2031.

By application, the Asia Pacific colostrum market is segmented into pharmaceuticals and dietary supplements, food and beverages, animal nutrition, and personal care. The pharmaceuticals and dietary supplements segment held 48.0% share of Asia Pacific colostrum market in 2023, amassing US$ 212.24 million. It is anticipated to garner US$ 375.01 million by 2031 to expand at 7.4% CAGR during 2023–2031.

By country, the Asia Pacific colostrum market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that the Rest of Asia Pacific captured 33.8% share of Asia Pacific colostrum market in 2023. It was assessed at US$ 149.18 million in 2023 and is likely to hit US$ 242.34 million by 2031, registering a CAGR of 6.3% during 2023–2031.

Key players operating in the Asia Pacific colostrum market are Titan Biotech Ltd, Pantheryx, Biodane Pharma A/S, Bionatin, Colostrum BioTec GmbH, Biostrum, Cure Nutraceutical PVT. LTD., INGREDIA s.r.o., I. Livanou IKE, and KERSIA GROUP, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com